Related Articles
Metastatic pancreatic cancer: Is gemcitabine still the best standard treatment? (Review)
Towards an updated view on the clinical management of pancreatic adenocarcinoma: Current and future perspectives (Review)
miR-15b promotes epithelial-mesenchymal transition by inhibiting SMURF2 in pancreatic cancer
Investigation into metastatic processes and the therapeutic effects of gemcitabine on human pancreatic cancer using an orthotopic SUIT‑2 pancreatic cancer mouse model
The role of protein kinase C-α in malignancies of the nervous system and implications for the clinical development of the specific PKC-α inhibitor aprinocarsen (Review)